Chronic Kidney Disease as a Comorbidity in Heart Failure

被引:44
作者
Szlagor, Magdalena [1 ]
Dybiec, Jill [1 ]
Mlynarska, Ewelina [1 ]
Rysz, Jacek [2 ]
Franczyk, Beata [1 ]
机构
[1] Med Univ Lodz, Dept Nephrocardiol, Ul Zeromskiego 113, PL-90549 Lodz, Poland
[2] Med Univ Lodz, Dept Nephrol Hypertens & Family Med, Ul Zeromskiego 113, PL-90549 Lodz, Poland
关键词
heart failure (HF); chronic kidney disease (CKD); GFR; ejection fraction; renin-angiotensin-aldosterone system inhibitors (RAAS-I); mineralocorticoid receptor antagonists (MRAs); sodium-glucose cotransporter 2 inhibitors (SGLT2); kidney replacement; angiotensin receptor-neprilysin inhibitor (ARNI); uremic toxins; finerenone; REDUCED EJECTION FRACTION; CARDIORENAL SYNDROME; PERITONEAL-DIALYSIS; OXIDATIVE STRESS; RENAL-FUNCTION; ALDOSTERONE; DYSFUNCTION; MECHANISMS; OUTCOMES; ANEMIA;
D O I
10.3390/ijms24032988
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heart failure (HF) is one of the greatest problems in healthcare and it often coexists with declining renal function. The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterioration. It is also associated with difficulties in the treatment of aggravating HF and chronic kidney disease (CKD) and, as a consequence, recurrent hospitalizations and death. As the worsening of renal function has an undeniably negative impact on the outcomes in patients with HF, searching for new treatment strategies and identification of biomarkers is necessary. This review is focused on the pathomechanisms in chronic kidney disease in patients with HF and therapeutic strategies for co-existing CKD and HF.
引用
收藏
页数:14
相关论文
共 95 条
  • [1] Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Boletis, John
    Toto, Robert
    Umpierrez, Guillermo E.
    Wanner, Christoph
    Wada, Takashi
    Scott, Charlie
    Joseph, Amer
    Ogbaa, Ike
    Roberts, Luke
    Scheerer, Markus F.
    Bakris, George L.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (07) : 1261 - 1269
  • [2] Heart Failure and Chronic Kidney Disease: Should We Use Spironolactone?
    Agrawal, Sahil
    Agrawal, Nikhil
    Garg, Jalaj
    Mohandas, Rajesh
    Gupta, Tanush
    Segal, Mark
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (02) : 147 - 151
  • [3] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Bakris, George L.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Joseph, Amer
    Filippatos, Gerasimos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) : 2219 - 2229
  • [4] Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload
    Banerjee, Debasish
    Ma, Jennie Z.
    Collins, Allan J.
    Herzog, Charles A.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (06): : 1186 - 1190
  • [5] Personalizing heart failure management in chronic kidney disease patients
    Banerjee, Debasish
    Wang, Angela Yee-Moon
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (11) : 2055 - 2062
  • [6] Management of Heart Failure Patient with CKD
    Banerjee, Debasish
    Rosano, Giuseppe
    Herzog, Charles A.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (07): : 1131 - 1139
  • [7] Anemia in Heart Failure Still Relevant?
    Beverborg, Niels Grote
    van Veldhuisen, Dirk J.
    van der Meer, Peter
    [J]. JACC-HEART FAILURE, 2018, 6 (03) : 201 - 208
  • [8] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
    Bhatt, Deepak L.
    Szarek, Michael
    Pitt, Bertram
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Cherney, David Z. I.
    Dwyer, Jamie P.
    Scirica, Benjamin M.
    Bailey, Clifford J.
    Diaz, Rafael
    Ray, Kausik K.
    Udell, Jacob A.
    Lopes, Renato D.
    Lapuerta, Pablo
    Steg, P. Gabriel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) : 129 - 139
  • [9] The severe cardiorenal syndrome: 'Guyton revisited'
    Bongartz, LG
    Cramer, MJ
    Doevendans, PA
    Joles, JA
    Braam, B
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (01) : 11 - 17
  • [10] Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: Insights from the SOLVD Treatment trial
    Bowling, C. Barrett
    Sanders, Paul W.
    Allman, Richard M.
    Rogers, William J.
    Patel, Kanan
    Aban, Inmaculada B.
    Rich, Michael W.
    Pitt, Bertram
    White, Michel
    Bakris, George C.
    Fonarow, Gregg C.
    Ahmed, Ali
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (01) : 151 - 156